Skip to content

Lescarden Inc LCAR Stock Analysis

  • EXPM
  • Stock
  • Market closed · opens Monday 9:30 AM ET

$0.00 unchanged at close Mar 8

Last close · Previous close $0.00

52-week change
down $0.00, 99.00%Price only
Distributions
$0.00Per share, last 12 months
Dividend yield
NoneLast 12 months

Price chart

$0.00unchangedWed, Mar 8 session

Use the left and right arrow keys to move along the chart.

Chart period
IEX trades, regular session · Times in ET
Price data

Trading

At last close

  • Previous close$0.00Mar 7
  • Volume0.00Mar 8 session
  • Avg. volume0.00Last 21 sessions
Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

Performance

Past performance, measured to the Mar 8 close. Total return includes reinvested dividends.

Return type
LCAR total returns
PeriodLCAR
Short term
1M
LCAR: unchanged
3M
LCAR: unchanged
YTD
LCAR: unchanged
1Y
LCAR: down 99.0%
Long term
5Y
LCAR: down 100.0%
−86.2% a year
10Y
LCAR: down 100.0%
−66.1% a year

$10,000 invested in LCAR 10 years ago (Mar 8, 2013) would be worth about $0 at the close on , with dividends reinvested.

All-time high

$1.22

Closing high on . Now 100.0% below that record.

Split-adjusted daily closes since May 9, 1997.

Stock splits

LCAR hasn’t split since its price history begins in 1997.

About Lescarden Inc

Lescarden Inc. (Lescarden), is engaged in research and development of biologic materials with a focus on wound healing, clinical skin care, osteoarthritis, and cancer applications. The Company's product line is led by Catrix Wound Dressing, a powder derived from bovine cartilage applied to non-healing wounds, such as decubitus ulcers, venous stasis ulcers, and diabetic ulcers. Lescarden also derives revenue from a line of Catrix-based skin care products targeting the plastic surgery, dermatology and medical spa markets. Sales of two supplements, Bio-Cartilage and Poly-NAG, a glucosamine polymer, also contributes to the Company's overall sales.

Sector
Healthcare
Industry
Medical Devices
Headquarters
New York, USA
Exchange
EXPM
Asset type
Common stock
Price history since

LCAR news

LCAR stock FAQ

What is LCAR stock’s price today?

Lescarden (LCAR) traded at $0.00 at the close on , unchanged from the previous close of $0.00.

If you invested $1,000 in LCAR 10 years ago, how much would you have now?

With dividends reinvested, $1,000 invested in LCAR on would be worth about $0 at the close on , a total return of −100.0%. The same $1,000 would be worth $0 if invested five years ago, $10 if invested one year ago, and $0 if invested 20 years ago. Past performance doesn’t predict future returns.

What is Lescarden’s market cap?

Lescarden’s market capitalization is about $0.1 thousand. That’s Tiingo’s daily market cap for , at that day’s closing price of $0.00 (how market cap works).

Does LCAR pay a dividend?

Lescarden hasn’t paid a dividend in the last twelve months.

What is LCAR’s all-time high?

LCAR’s highest closing price was $1.22 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.

Has LCAR stock ever split?

No. LCAR hasn’t split since its price history begins in 1997.

How has LCAR stock performed?

Including dividends and measured to the close on , LCAR has returned 0.0% so far this year and −99.0% over the past year, and −100.0% over five years (−86.2% a year). Past performance doesn’t predict future returns.

What sector and industry is Lescarden in?

Lescarden is in the Healthcare sector and the Medical Devices industry, and is headquartered in New York, USA.

What exchange does LCAR trade on?

Lescarden trades on the EXPM under the ticker symbol LCAR. Its price history on this dashboard begins on .

Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.

This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).

The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.

Contact Ryan

Get in touch

Contact Me

Have a question or want to work together? Fill out the form below and we'll get back to you as soon as possible.

Contact Form Demo

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.